CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 87 filers reported holding CHEMOCENTRYX INC in Q2 2017. The put-call ratio across all filers is 21.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $878,000 | -39.5% | 35,024 | -12.1% | 0.04% | -54.4% |
| Q4 2021 | $1,451,000 | +130.0% | 39,865 | +263.5% | 0.09% | +104.5% |
| Q2 2020 | $631,000 | +4.1% | 10,966 | -27.3% | 0.04% | 0.0% |
| Q1 2020 | $606,000 | +355.6% | 15,085 | +5.3% | 0.04% | +266.7% |
| Q2 2019 | $133,000 | -63.9% | 14,327 | -57.5% | 0.01% | -47.8% |
| Q4 2018 | $368,000 | +63.6% | 33,717 | +97.7% | 0.02% | +43.8% |
| Q2 2018 | $225,000 | +43.3% | 17,056 | +47.4% | 0.02% | +45.5% |
| Q1 2018 | $157,000 | -31.7% | 11,574 | -70.0% | 0.01% | -56.0% |
| Q4 2017 | $230,000 | +32.2% | 38,585 | +107.4% | 0.02% | -47.9% |
| Q2 2017 | $174,000 | +132.0% | 18,600 | +81.1% | 0.05% | +380.0% |
| Q1 2017 | $75,000 | – | 10,273 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |